Corporate Banner
Satellite Banner
Technology Networks Header
Friday, April 18, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Common Cents Systems and Translational Software Improve Efficiency in Pharmacogenetic Testing
Tuesday, February 04, 2014
The collaboration combines Apollo’s platform for operational excellence with Translational Software’s PGx decision support system.

Illumina Unveils Strategic Roadmap for Market Expansion
Saturday, February 01, 2014
Company positions for growth in key genomics segments, introduces new workflow solutions at investor day.

Roche Announces the Launch of SeqCap Epi Target Enrichment System
Saturday, February 01, 2014
Novel NGS target enrichment solution for methylation assessment.

First RayStation® Order in the United Kingdom
Saturday, February 01, 2014
Ninewells to be the first clinical installation of RayStation® in the United Kingdom.

Ready-to-Use Lentivirus for miRNA Expression and Inhibition
Saturday, February 01, 2014
AMSBIO’s anti-miRNA lentivirus are produced from the optimally designed anti miRNA lentivectors.

Almac Announces the Presentation of External Validation of ColDx Signature
Friday, January 31, 2014
Data presented supporting Almac developed colon signature as a significant predictor of risk of recurrence in stage II colon cancer.

First Blood Collection Tube for IVD Genomic DNA Testing Now Available
Wednesday, January 29, 2014
BD launches the PAXgene® Blood DNA Tube in Europe.

Maverix, $100,000 Order from University of Missouri For 99 Lives Cat Whole Genome Sequencing Initiative
Wednesday, January 29, 2014
Maverix Analytic Platform to be Used for Analysis and Hosting of Community of Discovery.

Energetiq Technology; Enhanced Performance EQ-99X-Series Laser-Driven Light Sources
Wednesday, January 29, 2014
The Laser-Driven Light Sources are introduced at Photonics West 2014.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 2437
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv